triazinate has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arseneau, JC; Beecham, J; Bundy, B; Homesley, H | 1 |
1 other study(ies) available for triazinate and Ovarian Neoplasms
Article | Year |
---|---|
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group study.
Topics: Antineoplastic Agents; Digestive System; Drug Eruptions; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Triazines | 1983 |